Skip to main content

King Charles III's wife Camilla, Queen Consort, tests positive for COVID https://ift.tt/EP9f6DH

Queen Consort Camilla has tested positive for COVID-19, Fox News Digital has learned.

"After suffering the symptoms of a cold, Her Majesty The Queen Consort has tested positive for the Covid virus," a statement from Buckingham Palace said. "With regret, she has therefore cancelled all her public engagements for this week and sends her sincere apologies to those who had been due to attend them." 

It remains unclear if King Charles III is also feeling ill.

KING CHARLES AND QUEEN CONSORT MARK FIRST JOINT ROYAL APPEARANCE SINCE DEBUT OF PRINCE HARRY'S MEMOIR ‘SPARE’

Camilla also tested positive for COVID-19 almost exactly one year ago. 

"Her Royal Highness The Duchess of Cornwall has tested positive for COVID-19 and is self-isolating. We continue to follow government guidelines," Clarence House said in a statement released on Feb. 14, 2022.

She tested positive days after news broke that then-Prince Charles had also tested positive for coronavirus. At the time, it was reported that Camilla had received the vaccine multiple times.

CLICK HERE TO SIGN UP FOR THE ENTERTAINMENT NEWSLETTER

Camilla's symptoms lingered, according to an interview she did shortly after she was ill.

"It's taken three weeks and still can't get shot of it," Camilla said during an International Women's Day event in 2022, according to Hello magazine. "Probably my voice might suddenly go, and I might start coughing and spluttering."

Queen Consort Camilla was set to appear alongside King Charles III this week in Milton Keynes. She also had solo engagements in the West Midlands.

King Charles III has tested positive for COVID twice now – once in March 2020 and again in Feb. 2022.



Labels:

Comments

Post a Comment

Popular posts from this blog

Miami-based Pelico, which offers a supply chain orchestration platform, raised a $40M Series B led by General Catalyst, bringing its total funding to $72M (Colin Campbell/Axios) https://ift.tt/kfjRq7o

Colin Campbell / Axios : Miami-based Pelico, which offers a supply chain orchestration platform, raised a $40M Series B led by General Catalyst, bringing its total funding to $72M   —  Supply chain orchestration platform Pelico raised $40 million in strategic financing led by General Catalyst, co-founder Tarik Benabdallah tells Axios Pro.
Post a Comment
Read more

Tesla's robotaxi service will launch in Austin with just ~10 cars that are geofenced to avoid complex intersections and monitored by backup teleoperators (Richard Waters/Financial Times) https://ift.tt/4Pt6rf8

Richard Waters / Financial Times : Tesla's robotaxi service will launch in Austin with just ~10 cars that are geofenced to avoid complex intersections and monitored by backup teleoperators   —  Autonomous ride-hailing service to make tentative debut in Austin, Texas, with only about 10 cars  —  For Elon Musk, tech's great showman …
Post a Comment
Read more

'Squad' Democrat calls for end of Israel's 'Gaza blockade' as he condemns Hamas terror attacks https://ift.tt/C91ITW6

New York Democrat Rep. Jamaal Bowman , a member of the group of House progressives known as "The Squad," took to social media Saturday to call for an end to the Gaza blockade and condemn the Iranian-backed Hamas terrorist attack on Israel. "I strongly condemn the horrific attacks by Hamas and am saddened by the loss of precious lives, especially on the holy day of Simchat Torah," Bowman said in a statement , which was shared to social media. "We need a way to end this deadly violence that is killing and traumatizing generations of Israelis and Palestinians alike — including the blockade of Gaza," he added. "I have been to the Gaza border and know that Israelis and Palestinians are constantly living in fear. We must work harder to ensure peace in the region." As new developments are made, Bowman, who made headlines recently after he pulled a fire alarm in Congress amid a vote to keep government open, said he and his team will be monitoring the...
Post a Comment
Read more